Company: BIAF
Filing Date: 2025-06-27
Form Type: POS AM
Source: 0001641172-25-016923
Chunk: 1

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-27
Form: POS AM
Chunk 1
---
 of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

| Large               
 accelerated filer ☐ | Accelerated         
 filer ☐             |
| Non-accelerated     
 filer ☒             | Smaller             
 reporting company ☒ |
|                     | Emerging            
 growth company ☒    |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

<div align='center'>EXPLANATORY NOTE</div>

This Post-Effective Amendment No. 3 (this “Post-Effective Amendment”) to the Registration Statement on Form S-1 (File No. 333-264463) (the “August 2022 Registration Statement” or the “Registration Statement”), of bioAffinity Technologies, Inc. (the “Company”) is being filed pursuant to the undertakings in the August 2022 Registration Statement to update and supplement the information contained in the August 2022 Registration Statement, which was originally declared effective by the Securities and Exchange Commission on August 29, 2022.

This post-effective amendment to the August 2022 Registration Statement (the “Post-Effective Amendment”) is being filed to serve as a Section 10(a)(3) update to the August 2022 Registration Statement and to make certain other updates to